Inovio Pharmaceuticals, Inc. (INO) quarterly income statement — complete revenue, gross profit & net income history
Inovio Pharmaceuticals, Inc. (INO) annual income statement — 27-year revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 65.34K | 116.99K | 0 | 100.76K | 0 | 102.65K | 388.45K | 225.97K | 114.94K | 124.67K | 9.15M | 784.39K | 199.07K | 839.12K | 291.7K |
| Revenue Growth % | - | -100% | -100% | - | -100% | - | 13.97% | -100% | -55.41% | -100% | -17.66% | -95.76% | -71.19% | -42.26% | -85.14% | 3038.22% | 187.51% | -46.36% | -84.96% | 23.51% |
| Cost of Goods Sold | 0 | 745.46K | 754.05K | 0 | 741.67K | 0 | 775.83K | 0 | 828.63K | 0 | 175.23K | 0 | 0 | 1.15M | 1.35M | 0 | 0 | 0 | 1.38M | 0 |
| COGS % of Revenue | - | - | - | - | - | - | 663.14% | - | 822.36% | - | 170.7% | - | - | 1002.34% | 1081.69% | - | - | - | 164.36% | - |
| Gross Profit | 0 | -745.46K | -754.05K | 0 | -741.67K | 65.34K | -658.84K | 0 | -727.86K | 0 | -72.58K | 388.45K | 225.97K | -1.04M | -1.22M | 9.15M | 784.39K | 199.07K | -540.07K | 291.7K |
| Gross Margin % | - | - | - | - | - | 100% | -563.14% | - | -722.36% | - | -70.7% | 100% | 100% | -902.34% | -981.69% | 100% | 100% | 100% | -64.36% | 100% |
| Gross Profit Growth % | 100% | -1240.85% | -14.45% | - | -1.9% | - | -807.79% | -100% | -422.1% | 100% | 94.07% | -95.76% | -71.19% | -621% | -126.61% | 3038.22% | 187.51% | -46.36% | 97.39% | 23.51% |
| Operating Expenses | 18.62M | 21.2M | 16.72M | 21.21M | 22.34M | 25.12M | 19.71M | 27.35M | 32.47M | 31.48M | 27.32M | 35.94M | 37.27M | 42.91M | 54.72M | 44.91M | 104.92M | 71.93M | 104.97M | 60.24M |
| OpEx % of Revenue | - | - | - | - | - | 38436.97% | 16847.64% | - | 32223.51% | - | 26615.58% | 9252.63% | 16491.97% | 37335.89% | 43895.15% | 490.61% | 13376.13% | 36133.33% | 12509.4% | 20653.16% |
| Selling, General & Admin | 7.8M | 7.88B | 7.22M | 7.88M | 8.56B | 9.02M | 6.83M | 8.61M | 9.38M | 10.57M | 10.07M | 9.93M | 13.52M | 12.74M | 12.6M | 11.82M | 48.46M | 15.95M | 12.67M | 13.16M |
| SG&A % of Revenue | - | - | - | - | - | 13811.69% | 5833.87% | - | 9307.14% | - | 9808.1% | 2555.07% | 5984.44% | 11082.44% | 10108.97% | 129.17% | 6177.61% | 8013.83% | 1509.86% | 4510.21% |
| Research & Development | 10.83M | 13.75M | 10.26M | 13.33M | 14.17M | 16.09M | 12.89M | 18.73M | 23.09M | 20.91M | 17.25M | 15.5M | 23.74M | 30.18M | 42.12M | 33.09M | 56.46M | 55.98M | 92.3M | 47.09M |
| R&D % of Revenue | - | - | - | - | - | 24625.29% | 11013.77% | - | 22916.37% | - | 16807.48% | 3991.04% | 10507.53% | 26253.46% | 33786.18% | 361.44% | 7198.53% | 28119.5% | 10999.54% | 16142.95% |
| Other Operating Expenses | 0 | -1000K | -754.05K | 0 | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.62M | -21.95M | -17.48M | -21.21M | -23.08M | -25.05M | -20.37M | -27.35M | -33.2M | -31.48M | -27.39M | -35.55M | -37.04M | -43.95M | -55.95M | -35.76M | -104.14M | -71.73M | -105.51M | -59.95M |
| Operating Margin % | - | - | - | - | - | -38336.97% | -17410.77% | - | -32945.87% | - | -26686.29% | -9152.63% | -16391.97% | -38238.24% | -44876.83% | -390.61% | -13276.13% | -36033.33% | -12573.76% | -20553.16% |
| Operating Income Growth % | 19.32% | 12.38% | 14.2% | 22.44% | 30.46% | 20.44% | 25.64% | 23.08% | 10.38% | 28.37% | 51.04% | 0.57% | 64.43% | 38.73% | 46.97% | 40.36% | -25.16% | -36.49% | -259.61% | -65.03% |
| EBITDA | -17.86M | -21.2M | -16.72M | -20.46M | -22.34M | -24.31M | -19.59M | -26.58M | -32.37M | -30.73M | -27.22M | -34.52M | -35.9M | -42.8M | -54.6M | -34.4M | -102.73M | -70.36M | -104.13M | -58.8M |
| EBITDA Margin % | - | - | - | - | - | -37199.21% | -16747.64% | - | -32123.51% | - | -26515.58% | -8886.75% | -15885.97% | -37235.89% | -43795.15% | -375.74% | -13096.37% | -35342.26% | -12409.4% | -20157.12% |
| EBITDA Growth % | 20.07% | 12.76% | 14.65% | 23.03% | 30.97% | 20.89% | 28.01% | 23% | 9.83% | 28.21% | 50.15% | -0.36% | 65.06% | 39.17% | 47.57% | 41.5% | -25.15% | -36.67% | -279.4% | -65.73% |
| D&A (Non-Cash Add-back) | 765.89K | 745.46K | 754.05K | 749.66K | 741.67K | 743.45K | 775.83K | 765.86K | 828.63K | 759.73K | 175.23K | 1.03M | 1.14M | 1.15M | 1.35M | 1.36M | 1.41M | 1.38M | 1.38M | 1.16M |
| EBIT | -6.01M | -19.68M | 3.76M | -45.5M | -23.52M | -19.69M | -19.38M | -25.17M | -32.24M | -30.29M | -24.72M | -33.62M | -35.22M | -40.34M | -54.15M | -37.47M | -108.18M | -76.6M | -106.47M | -59.69M |
| Net Interest Income | 363.85K | 439.59K | 449.34K | 552.11M | 610.64K | 808.08K | 852.59K | 1.11M | 1.31M | 1.32M | 1.54M | 1.63M | 1.85M | 1.89M | 1.58M | 1.05M | 544.18K | 356.33K | 419.15K | 289.9K |
| Interest Income | 363.85K | 439.59K | 449.34K | 552.11M | 610.64K | 808.08K | 852.59K | 1.11M | 1.31M | 1.5M | 1.82M | 1.94M | 2.17M | 2.21M | 1.89M | 1.37M | 857.67K | 669.81K | 899.46K | 766.27K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 177.83K | 282.32K | 313.49K | 313.49K | 313.49K | 313.49K | 313.49K | 313.49K | 313.49K | 480.31K | 476.37K |
| Other Income/Expense | 12.61M | 2.27M | 21.24M | -24.29M | -434.89K | 5.36M | 987.88K | 2.18M | 959.82K | 1.02M | 2.39M | 1.62M | 1.51M | 3.3M | 1.48M | -2.03M | -4.36M | -7.34M | -1.44M | -215.89K |
| Pretax Income | -6.01M | -19.68M | 3.76M | -45.5M | -23.52M | -19.69M | -19.38M | -25.17M | -32.24M | -30.47M | -25M | -33.93M | -35.53M | -40.65M | -54.46M | -37.78M | -108.5M | -79.07M | -106.95M | -60.17M |
| Pretax Margin % | - | - | - | - | - | -30140.48% | -16566.39% | - | -31993.31% | - | -24357.91% | -8734.77% | -15725.26% | -35364.76% | -43687.24% | -412.75% | -13831.97% | -39720.77% | -12745.28% | -20627.17% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -6.01M | -19.68M | 3.76M | -45.5M | -23.52M | -19.69M | -19.38M | -25.17M | -32.24M | -30.47M | -25M | -33.93M | -35.53M | -40.65M | -54.46M | -37.78M | -108.5M | -79.07M | -106.95M | -60.17M |
| Net Margin % | - | - | - | - | - | -30140.48% | -16566.39% | - | -31993.31% | - | -24357.91% | -8734.77% | -15725.26% | -35364.76% | -43687.24% | -412.75% | -13831.97% | -39720.77% | -12745.28% | -20627.17% |
| Net Income Growth % | 74.44% | 0.06% | 119.42% | -80.79% | 27.04% | 35.36% | 22.48% | 25.83% | 9.28% | 25.04% | 54.09% | 10.2% | 67.25% | 48.59% | 49.07% | 37.2% | -32.09% | -45.35% | -339.42% | -413.85% |
| Net Income (Continuing) | -6.01M | -19.68M | 3.76M | -45.5M | -23.52M | -19.69M | -19.38M | -25.17M | -32.24M | -30.47M | -25M | -33.93M | -35.53M | -40.65M | -54.46M | -37.78M | -108.5M | -79.07M | -106.95M | -60.17M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.07 | -0.28 | 0.05 | -0.87 | -0.61 | -725.11 | -0.70 | -894.28 | -1.19 | -1.31 | -1.10 | -1.52 | -1.61 | 136.92 | -2.42 | -0.16 | -0.48 | -0.38 | -0.51 | -0.29 |
| EPS Growth % | 88.52% | 99.96% | 107.8% | 99.9% | 48.74% | -55251.91% | 36.36% | -58734.21% | 26.09% | -100.96% | 54.55% | -850% | -235.42% | 36131.58% | -374.51% | 44.83% | -23.08% | -40.74% | -240% | -363.64% |
| EPS (Basic) | -0.07 | -0.28 | 0.05 | -0.87 | -0.61 | -0.51 | -0.70 | -894.28 | -1.19 | -1.31 | -1.10 | -1.52 | -1.61 | 136.92 | -2.42 | -0.16 | -0.48 | -0.38 | -0.51 | -0.29 |
| Diluted Shares Outstanding | 81.62M | 69.1M | 69M | 52.17M | 38.83M | 38.61M | 32.46M | 28.14M | 27.2M | 23.29M | 22.79M | 22.39M | 22.03M | 21.54M | 21.39M | 249.35M | 235.28M | 218.94M | 210.3M | 210.3M |
| Basic Shares Outstanding | 81.62M | 69.1M | 69M | 52.17M | 38.83M | 38.61M | 32.46M | 28.14M | 27.2M | 23.29M | 22.79M | 22.39M | 22.03M | 21.54M | 21.39M | 249.35M | 235.28M | 218.94M | 210.3M | 210.3M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |